Repare Therapeutics Inc.2024财年实现净利润-84.69百万美元，同比增加9.71%

市场透视2025-03-09

3月9日，Repare Therapeutics Inc.（RPTX.US）公布财报，公告显示公司2024财年净利润为-84.69百万美元，同比增加9.71%；其中营业收入为53.48百万美元，同比增加4.60%，每股基本收益为-2.00美元。从资产负债表来看，Repare Therapeutics Inc.（RPTX.US）总负债25.38百万美元，其中短期债务1.85百万美元，资产负债比为...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2518479144?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-03-09 00:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2518479144","market":"us","top_or_hot":-1,"title":"Repare Therapeutics Inc.2024财年实现净利润-84.69百万美元，同比增加9.71%","media":"市场透视","content":"<div>\n<p>3月9日，Repare Therapeutics Inc.（RPTX.US）公布财报，公告显示公司2024财年净利润为-84.69百万美元，同比增加9.71%；其中营业收入为53.48百万美元，同比增加4.60%，每股基本收益为-2.00美元。从资产负债表来看，Repare Therapeutics Inc.（RPTX.US）总负债25.38百万美元，其中短期债务1.85百万美元，资产负债比为...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000233abef9847&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Repare Therapeutics Inc.2024财年实现净利润-84.69百万美元，同比增加9.71%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRepare Therapeutics Inc.2024财年实现净利润-84.69百万美元，同比增加9.71%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-03-09 00:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000233abef9847&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>3月9日，Repare Therapeutics Inc.（RPTX.US）公布财报，公告显示公司2024财年净利润为-84.69百万美元，同比增加9.71%；其中营业收入为53.48百万美元，同比增加4.60%，每股基本收益为-2.00美元。从资产负债表来看，Repare Therapeutics Inc.（RPTX.US）总负债25.38百万美元，其中短期债务1.85百万美元，资产负债比为...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000233abef9847&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000233abef9847&s=b","article_id":"2518479144","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000233abef9847&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2518479144","pubTimestamp":1741449672,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"3月9日，Repare Therapeutics Inc.公布财报，公告显示公司2024财年净利润为-84.69百万美元，同比增加9.71%；其中营业收入为53.48百万美元，同比增加4.60%，每股基本收益为-2.00美元。从资产负债表来看，Repare Therapeutics Inc.总负债25.38百万美元，其中短期债务1.85百万美元，资产负债比为0.07，流动比率为0.07。机构评级：截至2025年3月9日，当前有4家机构对Repare Therapeutics Inc.目标价做出预测，其中目标均价为7.00美元，其中最低目标价为3.00美元，最高目标价为15.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","RPTX":"Repare Therapeutics Inc."},"translate_title":"Repare Therapeutics Inc. achieved net profits of-US $84.69 million in fiscal year 2024, a year-on-year increase of 9.71%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"RPTX":1},"content_text":"3月9日，Repare Therapeutics Inc.（RPTX.US）公布财报，公告显示公司2024财年净利润为-84.69百万美元，同比增加9.71%；其中营业收入为53.48百万美元，同比增加4.60%，每股基本收益为-2.00美元。从资产负债表来看，Repare Therapeutics Inc.（RPTX.US）总负债25.38百万美元，其中短期债务1.85百万美元，资产负债比为0.07，流动比率为0.07。机构评级：截至2025年3月9日，当前有4家机构对Repare Therapeutics Inc.目标价做出预测，其中目标均价为7.00美元，其中最低目标价为3.00美元，最高目标价为15.00美元。公司简介：Repare Therapeutics Inc 是一家专注于开发基于合成致死性的治疗方法，用于治疗癌症患者的精准医学肿瘤公司。该公司的重点是研究、开发和商业化针对特定基因定义患者群体肿瘤特定易感性的精准肿瘤药物。该公司主要收入来自加拿大。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2518479144","isCrawlerRequest":true}